Nektar Therapeutics (ITH0.STU) Q3 2026 Earnings

6AugConfirmed
Q2 2026
Next
-1.76
-1.62
-1.49
-1.35

Details

Expected EPS
-1.7614533993600001
Actual EPS
N/A
Surprise EPS
1.76
Surprise Percent
+100%

Description

Nektar Therapeutics (ITH0.STU) will report earnings of for Q3 2026 on August 06, 2026.

0 Comments

Share your thoughts